Asset Details
Do you wish to reserve the book?
Transcription factor FOXC2 regulates miR-145/ADAMTS5 axis to inhibit angiogenesis in hepatocellular carcinoma via circular RNA 0002898
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Transcription factor FOXC2 regulates miR-145/ADAMTS5 axis to inhibit angiogenesis in hepatocellular carcinoma via circular RNA 0002898
Do you wish to request the book?
Transcription factor FOXC2 regulates miR-145/ADAMTS5 axis to inhibit angiogenesis in hepatocellular carcinoma via circular RNA 0002898
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Transcription factor FOXC2 regulates miR-145/ADAMTS5 axis to inhibit angiogenesis in hepatocellular carcinoma via circular RNA 0002898
2025
Overview
Background
Circular RNAs (circRNAs), a novel class of single-stranded, covalently closed non-coding RNA molecules, have been increasingly recognized for their roles in the cellular landscape over the past decade. These molecules are predominantly localized within the cytoplasm of eukaryotic cells and have been implicated in the pathogenesis of a spectrum of cancers. Despite this, the specific contributions of circRNAs to hepatocellular carcinoma (HCC) have yet to be fully delineated.
Methods
Our research has identified that cyclic RNA0002898 is downregulated in HCC, with its reduced expression correlating with advanced tumor grade and diminished patient survival outcomes. Furthermore, we have demonstrated that the transcription factor forkhead box C2 (FOXC2) regulates the expression of cyclic RNA0002898, and diminished levels of cyclic RNA0002898 in HCC are associated with enhanced tumor cell proliferation, migration, and invasion in vitro. Mechanistic insights revealed that cyclic RNA0002898 could modulate the expression levels of the tumor suppressor a disintegrin and metalloproteinase with thrombospondin motif 5 (ADAMTS5) by antagonizing miR-145, thereby inhibiting angiogenesis and suppressing the growth of HCC cells.
Results
Our findings collectively elucidate the regulatory role, functional significance, and underlying mechanism of cyclic RNA0002898 in HCC, a previously uncharted relationship. The potential prognostic implications of cyclic RNA0002898 and its therapeutic potential as a target in HCC warrant further investigation.
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
/ Biomedical and Life Sciences
/ Carcinoma, Hepatocellular - blood supply
/ Carcinoma, Hepatocellular - genetics
/ Carcinoma, Hepatocellular - metabolism
/ Carcinoma, Hepatocellular - mortality
/ Carcinoma, Hepatocellular - pathology
/ Cell Proliferation - genetics
/ Female
/ Forkhead Transcription Factors - genetics
/ Forkhead Transcription Factors - metabolism
/ Gene Expression Regulation, Neoplastic
/ Health Promotion and Disease Prevention
/ Hepatoma
/ Humans
/ Liver Neoplasms - blood supply
/ Liver Neoplasms - metabolism
/ Male
/ MicroRNA
/ Neovascularization, Pathologic - genetics
/ Neovascularization, Pathologic - metabolism
/ Neovascularization, Pathologic - pathology
/ Oncology
